ENDPOINTS

Incyte's stock sinks as povorcitinib disappoints in hidradenitis suppurativa

Mar 17, 2025 - 16:35
 0
Incyte's stock sinks as povorcitinib disappoints in hidradenitis suppurativa
Read More

Tags:

Previous Article

Storrington in West Sussex named UK’s first European stork village

Next Article

New Battery Recycling Process From China Recovers 99.99% Of Lithium

Related Posts

Hikma takes Amarin's 'skinny label' fight to the Supreme Court

Hikma takes Amarin's 'skinny label' fight to the Suprem...

Feb 18, 2025  0

Roche no longer wants to be where ‘DNA sequencing goes to die’

Roche no longer wants to be where ‘DNA sequencing goes ...

Feb 20, 2025  0

At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionis

At $300M Kardigan startup, former MyoKardia team unveil...

Mar 7, 2025  0